Posts by Sandra Ansanay-Alex
Mara Graziani receives the prestigious Latsis Prize
Mara Graziani, research assistant at the HES-SO Valais-Wallis, has been awarded the prestigious Latsis prize worth CHF 25,000, which rewards young researchers for promising scientific and technological contributions made in Switzerland. Mara Graziani obtained her bachelor’s degree from La Sapienza University in Rome; she then continued her studies with a master’s degree at…
Read MoreTheraPPi Bioscience, MPC Therapeutics SA and dEEgtal awarded by the FIF
The Fongit Innovation Fund (FIF) has awarded three Geneva-based life sciences projects for their groundbreaking innovations. A seed loan of CHF 100,000 was awarded to TheraPPI Bioscience, whose technology tackles drug-resistant cancers drug-resistant cancers and uncurable rare diseases. A second of CHF 100,000 was granted to MPC Therapeutics SA, a spin-off from the…
Read MoreA new medtech hub in Bern
The Canton of Bern wants to establish itself as a leading international medical location by 2030. To achieve this, the Insel Group, the University of Bern, and the technology innovation center, CSEM, will combine their exceptional medical expertise and work together on research and development projects. Their goal is to strengthen the competitiveness of local…
Read MoreComphya SA announce successful inaugural surgery for erectile dysfunction in Spinal Cord Injury Patients
The first implantation of CaverSTIM, the medical devices invented by Swiss company Comphya, in spinal cord injury individuals has been successfully completed, heralding the commencement of a pivotal phase in research to address the specific needs of spinal cord injury patients. In collaboration with FMABC (Faculdade de Medicina do ABC), the clinical study…
Read MoreImpossible Materials wins the Mass Challenge Diamond Prize
The University of Fribourg chemtech spin-off has been granted CHF 120,000 in cash. The start-up provides cellulose white pigment solutions to enable businesses greener product formulations. In April, the start-up raised CHF 3.4 million to work on marketing its first product, a cellulose-based white pigment. The product is positioned as an alternative to…
Read MoreHUG wins award for smarter medicine in intensive care
At the 46th World Hospital Congress organised by the International Hospital Federation (IHF), the University Hospitals of Geneva (HUG) received the silver Mastercard Excellence Award in the field of quality of care and patient safety. The award went to the “Smarter medicine in intensive care” project. Bertrand Levrat, Chief Executive Officer of the…
Read MoreFIT Impact: 3 life sciences projects awarded
The first cohort to benefit from FIT Impact is now known. This programme run by the Foundation for Technological Innovation (FIT) and supporting low-tech projects with a strong social and environmental impact, has awarded grants of CHF 10,000 to ATIPIKEY, Impact Arti, NaviSanté, R.Unit, R2Home and thego.care. The six projects come from UNIL, HEIG-VD, H4…
Read MoreLASCCO SA and Abionic SA announce a partnership to commercialize a sepsis diagnostic solution in China
LASCCO SA and Abionic SA, both based in Biopôle in Epalinges, announced that they have signed a licensing agreement with global life science company, Fapon for the use of the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China. This agreement initiates a strategic cooperation between LASCCO, Fapon and Abionic SA, LASCCO’s…
Read MoreEarlySight SA and ArtemiX Biotech SA supported by the FIF
Two Geneva-based life sciences startups have been awarded the Fongit Innovation Fund (FIF) for their innovative projects. A seed loan has been awarded to EarlySight SA for its imaging-based detection tools in the healthcare sector and a grant has been provided to the ArtemiX project to continue the development of an innovative solution for treating chronic kidney…
Read MoreDebiopharm invests CHF 30 million in a life sciences building in Valais
This new facility will host some 2400 m2 of research laboratories, in Martigny where Debiopharm’s workforce jumped from 150 to 200 collaborators in twelve months. Debiopharm Research & Manufacturing (Debiopharm) is pleased to announce, on 25 October 2023, the launch and first groundbreaking of the construction work for its Innovation building in…
Read More